Makes me think of CYC and the sell down almost as soon as FDA approval. Not saying the same thing will happen with BOT.
I don't think it will be like CYC as BOT will hit the ground running. If it were to be like another company, it would be Dimerix as their positive results coincided with a halt for a CR outside of trading hours, which meant there was no chance for the share price to run. I could see that happening, and it wouldn't worry me.
It did not hinder the future share price of Dimerix, by the way.
BOT - Anything but charting, page-8831
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |